Skip to main content
Elsevier
View Cart

Books in Life sciences

Elsevier's Life Sciences collection helps researchers get comprehensive coverage and up-to-date information on the study of living organisms, their processes, and interrelationships, spanning disciplines like biology, genetics, and biochemistry, and addressing emerging trends such as genomics, biotechnology, and sustainability, essential for advancing knowledge and driving innovation in the field.

BooksJournals

    • Lipids and Membranes: Detection by Imaging and Lipidomics

      • 1st Edition
      • Volume 726
      • March 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 3 1 1 8 0
      • eBook
        9 7 8 0 4 4 3 4 3 1 1 9 7
      Lipids and Membranes: Detection by Imaging and Lipidomics, Volume 727 covers lipids, a chemically diverse set of biological molecules subject to rapid metabolism and transport. This dynamic behavior has motivated the development of methods across multiple disciplines for their detection and manipulation. Split into three parts, the chapters in this new release include Measurement of fatty acid esters of hydroxy fatty acids, Superresolution organelle imaging with lipophilic HIDE probes, Ultra-high resolution analysis of membrane lipids from 15N metabolically labeled mice, Superresolution lipid imaging with expansion microscopy, High-resolution phosphoinositide analysis in healthy versus disease cells, and much more.Additional chapters focus on Alkyne lipids as tracers of lipid metabolism, Imaging oxidative stress in biomembranes, Imaging the dynamics of phosphatidylinositol 4-phosphate metabolism, Lipidomics for studying sphingolipids in cell death, Non-invasive imaging of phosphoinositides with genetically encoded lipid biosensors, Profiling lipotypes at the single cell level in heterogenous populations, MS imaging of phosphoinositides, and much more.

    • Comprehensive Review of Lower Genital Neoplasms

      • 1st Edition
      • March 1, 2026
      • Nadereh Behtash + 3 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 4 5 6 4 4
      • eBook
        9 7 8 0 4 4 3 4 4 5 6 5 1
      Comprehensive Review of Lower Genital Neoplasms: With Case Discussion offers a practical, case-based guide to diagnosing and managing human papillomavirus (HPV)-related genital diseases. Designed for healthcare professionals, this resource simplifies complex concepts through engaging case presentations and high-quality colposcopy images, enhancing both visual learning and clinical skills.Comprehensive Review of Lower Genital Neoplasms: With Case Discussion offers a practical, case-based guide to diagnosing and managing human papillomavirus (HPV)-related genital diseases. Designed for healthcare professionals, this resource simplifies complex concepts through engaging case presentations and high-quality colposcopy images, enhancing both visual learning and clinical skills.This book bridges gaps in existing literature by combining evidence-based knowledge with hands-on teaching strategies, making it essential for clinicians to advance their expertise in HPV-related conditions.

    • Growth Hormone and Related Disorders: From Clinics to Diagnosis

      • 1st Edition
      • Volume 131
      • March 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 3 1 7 2 2
      • eBook
        9 7 8 0 4 4 3 4 3 1 7 3 9
      Growth Hormone and Related Disorders: From Clinics to Diagnosis, Volume 131 covers various topics related to growth hormone and its associated disorders when there is a GH excess, including their pathophysiology, clinical presentation and diagnosis. Chapters in this new release include Growth hormone: synthesis and regulation, GH and GnRH-gonadotropin secretion, Co-Secreting Pituitary Adenomas in Acromegaly: Classification, Diagnosis, and Treatment Strategies, Growth hormone and glycemic metabolism, Acromegaly: pathophysiology and etiology, Acromegaly: biochemical diagnosis, Acromegaly and clinical manifestations, and more.Additional sections discuss Gigantism, Acromegaly and genetics, Molecular markers of response to medical therapy in acromegaly, and Acromegaly and histopathology.

    • Live Biotherapeutics: Advancing Microbial Medicine

      • 1st Edition
      • Volume 220
      • March 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 3 1 9 0 6
      • eBook
        9 7 8 0 4 4 3 4 3 1 9 1 3
      Microbial therapeutics are rapidly reshaping modern medicine, with live biotherapeutics emerging as a promising frontier. By harnessing the power of beneficial microbes, these innovative treatments offer new hope for conditions that resist conventional drugs, including metabolic disorders and antimicrobial-resist... infections. As the demand for safer, more effective alternatives grows, understanding this field becomes increasingly vital. The upcoming book, Live Biotherapeutics: Advancing Microbial Medicine, will provide a comprehensive and accessible overview of the science, applications, and future potential of live biotherapeutics in transforming healthcare.

    • AI and Data Science in Medical Research

      • 1st Edition
      • March 1, 2026
      • Olfa Boubaker
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 6 3 8 5
      • eBook
        9 7 8 0 4 4 3 2 7 6 3 9 2
      AI and Data Science in Medical Research focuses on the integration of AI and data science into medical research, highlighting their impact on drug discovery, medical imaging, diagnostics, and genomic medicine. The book addresses the acceleration of therapeutic compound discovery and optimization of drug development pipelines through AI. The volume also discusses advancements in medical imaging, including early disease detection and neuroimaging. Additionally, it covers the application of AI in genomic medicine, offering insights into personalized treatment strategies.The volume concludes with an examination of AI's role in public health surveillance, particularly in disease detection and epidemiological research.

    • Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B

      • 1st Edition
      • Volume 399
      • March 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 4 1 3 8
      • eBook
        9 7 8 0 4 4 3 4 1 4 1 4 5
      Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part B delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers, Identification of circulating biomarkers for cancer therapy-related cardiovascular toxicity, Extracellular Vesicles as Dynamic Biomarkers: Monitoring Therapeutic Responses and Drug Resistance in Cancer, and more.This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.

    • Roadmap to Successful Digital Health Ecosystems

      • 2nd Edition
      • March 1, 2026
      • Evelyn Hovenga + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 4 0 7 3 1
      • eBook
        9 7 8 0 4 4 3 4 4 0 7 4 8
      Roadmap to Successful Digital Health Ecosystems: A Global Perspective, 2nd edition, explores the transformative integration of digital health technologies to enhance healthcare delivery and patient outcomes. This book provides a comprehensive overview of the evolving landscape of digital health, focusing on next-generation systems and the role of artificial intelligence in creating efficient healthcare ecosystems. The revised content covers topics such as regional implementation experiences, workforce management, and precision healthcare. New chapters highlight advancements in digital health technologies, case studies from Jamaica and Africa, and strategies for addressing fragmentation in healthcare systems. The book emphasizes ethical AI use and proactive, integrated healthcare approaches. For the academic audience, this revision serves as an essential resource, compiling cutting-edge research and practical applications that inform best practices in digital health. It equips researchers, educators, and practitioners with the knowledge needed to navigate the complexities of digital health ecosystems and drive innovation in their fields.

    • Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies

      • 1st Edition
      • March 1, 2026
      • Shuvomoy Banerjee + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 5 7 1 7 3
      • eBook
        9 7 8 0 4 4 3 4 5 7 1 8 0
      Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies offers a comprehensive exploration of the persistent challenge of cancer chemoresistance. Drawing upon the latest research in cancer biology, molecular biology, biotechnology, and nanotechnology, this book unpacks the multifaceted nature of drug resistance. It examines how changes in cellular signaling, genetic adaptations, and the tumor microenvironment contribute to cancer cells’ ability to withstand treatment. By presenting interdisciplinary perspectives, the book aims to empower researchers, clinicians, and professionals with the necessary insight to advance therapeutic strategies and improve outcomes for patients facing refractory cancers.Beyond its focus on underlying mechanisms, the book delves into cutting-edge drug delivery technologies such as nanomedicine and biomimetic approaches, which enhance drug precision and reduce unintended effects. It also discusses the integration of breakthrough tools like CRISPR-Cas9 and artificial intelligence in the development of next-generation therapies.

    • The Story of GLP-1

      • 1st Edition
      • March 1, 2026
      • Jens Juul Holst
      • English
      • Hardback
        9 7 8 0 4 4 3 3 3 2 8 7 6
      • eBook
        9 7 8 0 4 4 3 3 3 2 8 8 3
      The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity offers a compelling narrative about the discovery and development of the hormone GLP-1, which has revolutionized modern approaches to diabetes and obesity. Award-winning scientist Professor Jens Juul Holst, alongside co-authors Professor Sten Madsbad, Professor Jens Meldgaard Bruun, and Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen, trace the scientific breakthroughs and clinical advances that have made GLP-1 therapies, such as Ozempic and Wegovy, essential tools for improving blood sugar control and promoting meaningful, lasting weight loss in patients worldwide.The book explores the rising global prevalence of obesity and diabetes, emphasizing the urgent need for innovative solutions. It critically examines traditional treatments, noting their limitations in sustaining weight loss or reducing complications. The narrative details the paradigm shift brought by GLP-1 medications, including liraglutide and semaglutide, which offer improved cardiovascular outcomes and significant health benefits. The authors also address ongoing challenges of accessibility and affordability, prompting important societal discussions about equitable distribution and funding for these lifechanging therapies.

Related subjects

Biochemistry biophysics

Biotechnology

Endocrinology

Life sciences general

Molecular biology cellular biology and genetics

Physiology